Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody
- PMID: 12874234
- DOI: 10.4049/jimmunol.171.3.1423
Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody
Abstract
Both CD4(+) T cells and B cells are critical for defense against Pneumocystis carinii infection; however, the mechanism by which B cells mediate protection is unknown. We show that P. carinii-specific IgM is not sufficient to mediate clearance of P. carinii from the lungs since CD40-deficient mice produced normal levels of specific IgM, but were unable to clear the organisms. Using chimeric mice in which the B cells were deficient in CD40 (CD40KO chimeras) we found that clearance of P. carinii infection is delayed compared with wild-type controls. These CD40KO chimeric mice produced normal levels of P. carinii-specific IgM, but did not produce class-switched IgG or IgA. Similarly, clearance of P. carinii was delayed in mice deficient in FcgammaRI and III (FcgammaRKO), indicating that P. carinii-specific IgG partially mediates opsonization and clearance of P. carinii. Opsonization of organisms by complement did not compensate for the lack of specific IgG or FcgammaR, since C3-deficient and C3-depleted FcgammaRKO mice were still able to clear P. carinii. Finally, micro MT and CD40KO chimeric mice had reduced numbers of activated CD4(+) T cells in the lungs and lymph nodes compared with wild-type mice, suggesting that B cells are important for activation of T cells in response to P. carinii. Together these data indicate that P. carinii-specific IgG plays an important, but not critical, role in defense against P. carinii. Moreover, these data suggest that B cells also mediate host defense against P. carinii by facilitating CD4(+) T cell activation or expansion.
Similar articles
-
Neonatal T cells in an adult lung environment are competent to resolve Pneumocystis carinii pneumonia.J Immunol. 2001 May 1;166(9):5704-11. doi: 10.4049/jimmunol.166.9.5704. J Immunol. 2001. PMID: 11313412
-
IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection.J Immunol. 2003 Jan 15;170(2):1002-9. doi: 10.4049/jimmunol.170.2.1002. J Immunol. 2003. PMID: 12517967
-
T cell costimulatory molecule function determines susceptibility to infection with Pneumocystis carinii in mice.J Immunol. 2003 Aug 15;171(4):1969-77. doi: 10.4049/jimmunol.171.4.1969. J Immunol. 2003. PMID: 12902500
-
Lymphocytes in host defense against Pneumocystis carinii.Semin Respir Infect. 1998 Dec;13(4):330-8. Semin Respir Infect. 1998. PMID: 9872630 Review.
-
Host defense against Pneumocystis carinii: more than the CD4+ lymphocyte.J Lab Clin Med. 1996 Nov;128(5):448-9. doi: 10.1016/s0022-2143(96)90040-2. J Lab Clin Med. 1996. PMID: 8900286 Review. No abstract available.
Cited by
-
CD40 Expression by B cells is Required for Optimal Immunity to Murine Pneumocystis Infection.bioRxiv [Preprint]. 2024 Feb 5:2024.02.05.578900. doi: 10.1101/2024.02.05.578900. bioRxiv. 2024. Update in: J Infect Dis. 2024 Oct 16;230(4):1033-1041. doi: 10.1093/infdis/jiae133. PMID: 38410485 Free PMC article. Updated. Preprint.
-
Germline IgM predicts T cell immunity to Pneumocystis.JCI Insight. 2022 Sep 8;7(17):e161450. doi: 10.1172/jci.insight.161450. JCI Insight. 2022. PMID: 35917185 Free PMC article.
-
IL-9 Deficiency Promotes Pulmonary Th17 Response in Murine Model of Pneumocystis Infection.Front Immunol. 2018 May 25;9:1118. doi: 10.3389/fimmu.2018.01118. eCollection 2018. Front Immunol. 2018. PMID: 29887863 Free PMC article.
-
Severe pneumocystis jiroveci pneumonia in a patient on temozolomide therapy: A case report and review of literature.Respir Med Case Rep. 2017 Aug 12;22:179-182. doi: 10.1016/j.rmcr.2017.08.012. eCollection 2017. Respir Med Case Rep. 2017. PMID: 28861334 Free PMC article.
-
Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease.Immunol Res. 2011 Aug;50(2-3):175-80. doi: 10.1007/s12026-011-8218-x. Immunol Res. 2011. PMID: 21717077 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous